addressing the gaps in cancer care Across Canada, people living with and beyond cancer navigate systems that often overlook their needs. Decisions about drugs, diagnostics, and delivery models are frequently made without considering the lived realities of patients, caregivers, and frontline teams. Policies tend to prioritize budgets over people. Data is often fragmented, and the pace of innovation has surpassed the processes designed to evaluate and fund it. This creates dela

In the world of personalized medicine, biomarkers are pivotal. These biological markers, which can include genes, proteins, or other molecules, help tell us what’s happening inside the body—whether it’s a normal process or an indication of disease. Essentially, biomarkers act as signals, offering clues that can aid in diagnosis, predict how a disease might progress, and guide tailored treatment plans, especially for complex diseases like cancer. What are Biomarkers? Biomarker

A Resource Guide Genomic testing is an important tool that can reveal the unique genetic characteristics of your cancer, guiding more personalized treatment options. But knowing when and how to ask your oncologist about it can help you make informed decisions in your cancer care. This guide provides an overview of genomic testing, signs it may be relevant to your treatment, and questions to discuss with your oncologist. What is Genomic Testing? Genomic testing analyzes the DN

Precision medicine is transforming cancer care by offering treatments tailored to individual genetic profiles. At the heart of this approach is data sharing—the process of gathering and using medical data from many people to advance research and treatment options. But how exactly does data sharing impact your care? Let’s break it down. 1. How Data Sharing Powers Better, Faster Cancer Treatments In precision medicine, doctors and researchers rely on large amounts of data to un

Precision Oncology - Frequently Asked Questions (FAQ) What is #KNOWvember #KNOWvember is Precision Oncology Awareness Month — a national effort to build shared understanding of what precision oncology is, why it matters, and who can benefit from it, and to advocate for a system where everyone who can benefit actually receives it. It’s about making the science clear, the language simple, and the purpose shared — so patients, caregivers, and clinicians across Canada have the kn

As we celebrate Precision Oncology Awareness Month, we reflect on the transformative role advanced biomarker testing plays in revolutionizing cancer care. By uncovering the unique genetic and molecular characteristics of each patient’s cancer, these groundbreaking tools empower clinicians to tailor treatments to individual needs. The result is not only improved patient outcomes—including enhanced quality of life and survival—but also a more efficient healthcare system through

While precision medicine has the potential to revolutionize cancer treatment, disparities in access to genomic testing and targeted treatments persist among various populations. To ensure equitable healthcare, we need to better understand how specific genomic mutations disproportionately affect certain groups and build a system that represents all of Canada’s diversity. Importance of EDI in Precision Medicine Equity: Ensures fair access to genomic testing and treatment option

In the era of precision oncology, data isn't just information—it's a lifeline. When shared, it enables doctors to tailor treatments, researchers to make groundbreaking discoveries, and ultimately, patients to receive care that’s not only more effective but also designed with their unique needs in mind. This November, #KNOWvember, we’re focusing on - how can we put data to work for precision oncology? The Promise of Data in Precision Oncology Cancer treatment has come a long w